Control:The routine therapy

3 trials

Sponsors

State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China, The First Affiliated Hospital of Henan University of CM

Conditions

Pulmonary Hypertensionchronic obstructive pulmonary disease, pulmonary hypertensioncoronary atherosclerotic heart disease

Early Phase 1

A Randomized Controlled Pilote Trial for Efficacy and Safety of Tetramethylpyrazine (TMP) Phosphate in the Treatment of Pulmonary Hypertension

RecruitingChiCTR1800018664

State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, ChinaPulmonary Hypertension

Start: 2018-09-29Updated: 2019-09-16

Phase 4

A Randomized Controlled Trial for Efficacy and Safety of berberine on vasculopathy in patients with NSTE-ACS after stenting

RecruitingChiCTR1800018742

The First Affiliated Hospital of Henan University of CMcoronary atherosclerotic heart disease

Start: 2018-10-15Updated: 2018-10-15

Unknown Phase

A multicenter study for a monomer drug derived from traditional Chinese medicine in the treatment of chronic obstructive pulmonary disease and its complications

Active, not recruitingChiCTR1800016955

State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Diseases, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, Chinachronic obstructive pulmonary disease, pulmonary hypertension

Start: 2018-08-01Updated: 2024-12-02

Related Papers

Efficacy and safety of Bufei Huoxue capsules in the treatment of stable COPD: A multicenter, double-blind, placebo-controlled, randomized clinical trial

Pharmacological Research - Modern Chinese Medicine2025-06-211 citations

Efficacy and safety of tetramethylpyrazine phosphate on pulmonary hypertension: study protocol for a randomized controlled study.

2019-12-167 citations